Metabolic Disease Drug Development
Conference - Boston, MA, United States
Expanding epidemic. Unmet medical need. Enormous market potential.
Where will innovation come from in the metabolic drug pipeline? What clinical strategies will satisfy regulators?
Answering these questions holds the key to dominating the enormous and expanding cardiometabolic market.
Continuing unmet medical need, bottlenecks in the pipeline and a harsh regulatory climate remain strong drivers for enhancing your metabolic drug development strategy.
By giving you unparalleled access to the minds behind the most promising drugs in development, Metabolic Disease Drug Development will provide the perfect platform to address these concerns and direct your preclinical and clinical development strategy.
Metabolic Disease Drug Development guarantees strong representation and candid discussion from senior level figures at Pfizer, Merck, BMS and the most innovative biotechs in the field. It will provide valuable insight into identifying and validating new metabolic drug targets, streamlining clinical strategy and speeding the passage of your drugs to market.
(Courtesy of http://www.metabolicdisease-drugdev.com/)
Tue, Oct 23, 2012 - Tue, Oct 23, 2012
Hyatt Regency Boston
One Avenue de Lafayette, Boston, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
